Vanda Pharmaceuticals
VNDA
VNDA
122 hedge funds and large institutions have $481M invested in Vanda Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 46 increasing their positions, 33 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
10% less capital invested
Capital invested by funds: $538M → $481M (-$56.2M)
Holders
122
Holding in Top 10
4
Calls
$11.6M
Puts
$3M
Top Buyers
| 1 | +$16.2M | |
| 2 | +$8.03M | |
| 3 | +$7.74M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$3.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.1M |
Top Sellers
| 1 | -$30.5M | |
| 2 | -$5.2M | |
| 3 | -$4.44M | |
| 4 |
AC
Armistice Capital
New York
|
-$4.31M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$2.98M |